Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti ...

IHH Healthcare, supported by Mitsui, has increased its compensation claim against Daiichi Sankyo to $1.3 billion in the Tokyo District Court, related to the Fortis Healthcare acquisition.

NTK had filed a claim in October 2023, seeking damages of 20 billion yen from Daiichi Sankyo for allegedly obstructing its efforts to complete its open offers to acquire shares in Indian hospital ...

New Delhi, May 20 (PTI) Malaysia's IHH Healthcare is seeking JPY 200 billion (Rs 11,800 crore) in damages from Japan's Daiichi Sankyo for blocking its bid for control of Indian hospital operator ...

Northern TK Venture Pte Ltd. (NTK), a Singapore-based indirect subsidiary of IHH Healthcare Berhad, has sharply escalated its legal claim against Japan’s Daiichi Sankyo Co. Ltd., seeking damages ...

IHH Healthcare said on Tuesday its unit has filed a petition in a Tokyo court to revise damages sought from Japan's Daiichi Sankyo over its Fortis Healthcare stake buy to up to 109.3 billion ...

IHH Healthcare said on Tuesday its unit has filed a petition in a Tokyo court to revise damages sought from Japan's Daiichi Sankyo over its Fortis Healthcare stake buy to up to 109.3 billion rupees ...

Credit: Orawan Pattarawimonchai / Shutterstock. Daiichi Sankyo and MSD have announced the first subject dosing in the Phase III Ideate-Esophageal01 trial, assessing the safety and efficacy of ...

This was followed by an accident at the Fukushima Daiichi Nuclear Power Station, which was ultimately categorized as a Level 7 — Major Accident — on the International Nuclear and Radiological Event ...

Sales rise 109.76% to Rs 70.06 crore Net profit of Dai-ichi Karkaria rose 468.81% to Rs 6.20 crore in the quarter ended March 2025 as against Rs 1.09 crore during the previous quarter ended March 2024 ...